CAS No.:532-03-6
Name: Methocarbamol
Details Introduction
TOXICITY DATA with REFERENCE:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | oral | 2gm/kg (2000mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 398, 1972. | |
| hamster | LD50 | intraperitoneal | 1050mg/kg (1050mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA |
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |
| hamster | LD50 | oral | 1410mg/kg (1410mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA BEHAVIORAL: MUSCLE WEAKNESS |
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |
| mouse | LD50 | intraperitoneal | 950mg/kg (950mg/kg) | Toxicology and Applied Pharmacology. Vol. 2, Pg. 264, 1960. | |
| mouse | LD50 | intravenous | 774mg/kg (774mg/kg) | Drugs in Japan Vol. 6, Pg. 836, 1982. | |
| mouse | LD50 | oral | 812mg/kg (812mg/kg) | Drugs in Japan Vol. 6, Pg. 836, 1982. | |
| mouse | LD50 | subcutaneous | 780mg/kg (780mg/kg) | BEHAVIORAL: ANTICONVULSANT | Acta Pharmacologica et Toxicologica. Vol. 19, Pg. 247, 1962. |
| rabbit | LD50 | intravenous | 680mg/kg (680mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: REGIDITY BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) |
International Journal of Neuropharmacology. Vol. 5, Pg. 305, 1966. |
| rat | LD50 | intraperitoneal | 815mg/kg (815mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 242, 1967. |
| rat | LD50 | oral | 1320mg/kg (1320mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA |
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |
Consensus Reports:
SAFETY PROFILE:
Hazard Codes:
Xn
Risk Statements 22-42/43
R22: Harmful if swallowed.
R42/43: May cause sensitization by inhalation and skin contact.
Safety Statements: 36
S36: Wear suitable protective clothing.
WGK: Germany 3
RTECS: TY8750000
Standards and Recommendations:
Analytical Methods:
Related Searches
Related Suppliers
- Dayang Chem (Hangzhou) Co.,Ltd.
- Hangzhou Sartort Biopharma Co., Ltd
- Wuhan Fortuna Chemical Co.,Ltd
- Xiamen Hisunny Chemical Co.,Ltd
- Afine Chemicals Limited
- Zhejiang Haizhou Pharmaceutical Co., Ltd.
- Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
- MEDICAL , PHARMACEUTICAL AND DRUG STORE
- Stellar Chemical Laboratories Pvt. Ltd
- Ningbo Smart Pharmaceutical Co.,Ltd.
- Shanghai Sunwise Chemical Co., Ltd
- Synches Co., Ltd.
- Shandong Xinhua Pharmaceutical Co.,Ltd
- Hubei Hengluyuang Technology Co.,Ltd
- Zhejiang Chemline industries Co.,Ltd.
- Laboratorios Argenol
- Gennex Laboratories Limited
- Pan Drugs Limited
- Lianyungang Runhou International Co.,Ltd
- Hangzhou Showland Technology Co., Ltd.
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione

